Announcements Trials

Browse Landscape

Status

Suspended 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Bevacizumab 4 Specimen Handling 3 Magnetic Resonance Spectroscopy 2 Everolimus 2 Biopsy 2 trametinib 1 relatlimab 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 fluoromisonidazole 1 fludarabine phosphate 1 antineoplaston AS 2-1 1 antineoplaston A10 1 aldesleukin 1 X-Rays 1 Transcranial Magnetic Stimulation 1 TPI-287 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Nivolumab 1 Niacinamide 1 Niacin 1 Metformin 1 Mental Status and Dementia Tests 1 Magnetic Resonance Imaging 1 Lomustine 1 Lasers, Solid-State 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Biological Specimen Banks × CNS × Clear all

NCT04657146 2025-11-12

LAMB-G

Duke University

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡